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This thesis deals with the developlnent of a wearable glucose sensor fbr possible use in
the treatment of diabetes mellitus.
ln chapter one some general information on diabetes mellitus is presented as well as
dif ferent strategies of medical treatment of the disease. Diabetes mellitus is a disease char-
acterised by a relative or absolute deficiency of biologically active insulin. As a result car-
bohydrate ancl f'at metabolisrn are deranged. Loss of control of the blood glucose level is
of main concent, because of short-term and severe long-term complications. Therapy in-
volves substitution of insulin to regain control of the blood glucose level. Nornroglycae-
rnia, though. can sti l l  not be achieved with multiple daily insulin injections. Several ap-
proaches to come to a more physiological insulin administration to improve diabetic treat-
ment are discussed.
- Transplantation of the pancreas or isolated islets of Langerhans
- Open-loop insulin dosage systems, mainly conceming pre-programnable insulin pumps
- Closed-loop insulin dosage systems, in which a programmable insulin pump is con-
trolled on the measurement of the actual body glucose concentration with the use of a
glucose sensor. Final goal is to come to a complete artif icial pancreas.
Prclblerns related to the construction and realisation of a long-term reliable glucose sensor
are discussed. An overview of all strategies presented sofar to overcome these problems
is g iven.
The design of the glucose sensor, presented in this thesis. is described in chapter two.
The sensor consists of an oxygen electrode as detector and a dynamic enzyme microdia-
lysis system as selector. Glucose is dialysed fiom the tissue using a hollow fiber mem-
brane, which can be placed subcutaneously. Within the perfusion system the enzyme glu-
cose oxidase catalyzes the reaction of glucose with oxygen. The reduced oxygen conccn-
tration of the dialysate is measured on-line with a Clark type oxygen electrode and can be
related to the glucose concentration. In this design problems of biocompatibil i ty, enzyme
instabil ity and oxygen limitation can be circumvented. In vitro response curves of the glu-
cose sensor show a good correlation between the sensor output current and the glucose
concentration. Linear effect of enzyrrre perfusion rate and hollow flber membrar.re l ngth
could be den.ronstrated.
As the glucose sensor is based on the principle of rnicrodialysis, a crucial part of the
system is the hollow flber rnenrbrane. The construction of these membranes is described
in chapter three. The hollow fiber me,mbrane is the only part of, the systenr to be placed
in the body. Therefore it has to be small and should be conrposed of inert materials. Mem-
branes used in the construction ofthe hollow fiber should have pores, large enough to en-
able glucose diffusion into the microdialysis system, while enzyme diffusion into the
body has to be prevented. Two types of tubular membrane were used:
Polysullbne hollow flber (MWCO 10.000 Daltonl internal diameter 0.-5 mm. outer
d iameter  1.0 mm)
- Cellulose hollow fiber (MWCO 9.000 Dalton; internal diameter 150 Um, outer dia-
meter  186 um)
l 0 l
Scveral hollow' fiber constructions are discussed. Improvements were made towards pa-
tient cornfbrt, 11ow capacitv and protection against enzyme leakage.
In chapter four diffelent types of pumps are evaluated. The pump should be capable
of delivering flxed flow rates, which have to be as constant as possible. All irregularit ies
in the l low pattem have direct eff 'ect on the luminal glucose concentration of the system,
thus disturbing the measurenrents. To achieve a wearable sensor the pump has to be mini-
aturizable and 1br continuous long-term use its energy consumption should be low. With
thc usc of a roller pump or a piston pump it becanre possible to recirculate the glgcose oxi-
dase solution. Some adaptations, however, were neccssary to maintain a reliable sensclr
signal. The oxygen consumed in the reaction had to be replenished. By introducing a gas-
pernreable tube after the electrode a constant basic oxygen concentration of the perfusion
tluid could be established. The negative effect of hydrogen peroxide, fbrmed in the enzy-
matic reaction, cln the enzyme stabil ity was eliminated by adding the enzyme catalase tc'r
the perfusion tluid to remove the hydrogen peroxide. In this way a closed loop microdia-
Iysis s1'51em was realised.
In chapter five the glucose sensor is tested in vivo in healthy volunteers. Twelve oral
glucose tolerance tests were perfbrmed in which the subcutaneous glucose sensor signal
was cornpared with the venous blood glucose concentration. Conelation between the sen-
sor signal and the blood glucose concentration prclved to be good. The delay observed be-
tween changes in glucose concentration in blood and subcutaneous tissue is not caused by
the glucose sensor, but is a result of the temporary clisturbance o1-the quil ibrium between
the intravascular and intercellular compartment with rapidly changing glucose concentra-
tions. Calibrating the sensor signal on steady state blood glucose level resulted in lower
calibration factors than those determined in vitro for the same hollow flber. This sugges-
ted that subcutaneous tissue glucose levels are lower than venous bkxrd glucose lcvels. In
one experiment i was shown that the glucose sensor sti l l  rneasured reliably nine days after
insertion of the hollow fiber.
In chapter six the glucose sensclr is tested in diabetic patients. Asked to on-rit heir
nrorning insulin injection the patients arrived with high blood glucose levels. After plac-
ing the glucose sensor, insulin was administered inlravenously resulting in a very fast de-
cline of blocld glucose concentration. With these experiments the maximum delay be-
tween the subculaneous sensor signal and the venous blood glucose concentration could
be determined, being 22 minutes. Despite this delay, correlation between tlre glucose sen-
sor signal and the venous blood glLrcose concentration proved to be good. In some excep-
tional cases, though, flow irregulirrit ies and poor sensor sensitivity disturbed the measure-
ments.
Chapter seven deals with the aspect of calibration of the glucose sensor. In vivo expe-
rinrents were pcrformed in twelve healthy volunteers and twelve diabetic patients. Blood
glucose concentration was clamped at two diff-erent levels allowing a two poiltt calibra-
tion of the sensor signal. Before and after each test the glucose sensor was calibrated in
vitro. A good corrclation was observed between the sensitivity of the sensor in vivo and
in vitro. confirming the rehabil ity of the glucose sensor microdialysis ystem. This is of
particular interest, since glucose sensor calibration is a nuch discussed problem. No other
research group so lar could achieve any correlation between sensitivity in vitro and in
vir 'o. This obsen,ed correlation in 24 humans also enabled a calculation of the absolute
glucose concentration in thc subcutaneous tissue. being 43olc ofthe blood glucose concen-
tration. Furthermore. the low interindividLral variation of the quotient vitro/vivo indicatcs
that thc subcutaneous abdominal f 'atty t issue is a gocld measuring site fbr glucose.
To validate tlre nieasurernent of the actual subcutaneolls glucose concentration rvith
the glucose sensor, a different technique was developed to measure directly the subcuta-
neous glucose concentration, described in chapter eight. Sampling of subcutrtncous inter-
ccllular f luid is established using a fi l tration technique in which a vacutainer is connected
to subcutancously insertecl hollow fiber mernbranes.
Experiments were pedbrmed in l3 healthy volunteers. Apart from the subcutaneous
flltration san.rples, glucose was lollowed subcutaneously with the glucose sensor and
blood sarnples were taken as a reference. Init ially the fi l trale values were cqual to blclod
glucose concentration, but after a six hour clecline period, the value remained constant at
467c of the sirnultancously detcln'rined bloocl glucose values. The glucose sensor, calibr-
ated in vitro, nreasured 44%: <t[ the mean venous blood glucose concentration. The init ially
high glucose levels of the fl l trate are explained to be caused by the disruption o1-local
blood vessels and cells with the inse rtion of the nrembranes. Due tcl the suctiort applied on
the membranes. wound healing is only cornpletcd alier several hours atier which thc
normal situation is restored and true interstit ial glucose concentrations are measured. Thc
close 2g1gcment between the two indepenclent methods supports the statement that real
glucose concentration in subcutaneous fatty t issue is about half of the blood glucose
value. An anatomical model was developccl, which mailc' i t possible to explain most of thc
conll icting results and theories presented solar.
More inlirrnration on the actual subcutaneous glr-rcose concentration is gtrthered in
chapter nine. A new method was developed to validate'the anatomical model. Saline rtr
glucose solutions in saline were brclught in an ultrafi ltration hollow flber rnentbranc. in-
serted into subcutaneous tissue. The fluid was allowed to equil ibrate with its surrounding
after which the sarnple was collectecl. Again, subcutaneous glucosc concentration prol'ecl
to be lower than the simultaneously measured blood glucose level. Several othcr in vivo
experinrents cln hurnans and dogs made it possible ft) draw a l lnal conclusion on the actual
situation in the subcutaneous tissue. These results are of great inrportance, since know-
ledgc on the actual amount ofglucose present at the nreasuring site ofthe glucose sensor
is a prerequisite for the successll l introduction of such a device in diabetic treatment.
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